With healthcare's growing emphasis on the comparative effectiveness of new drugs in relation to what is already available, recent times have brought forth an expectation for developers to prove additional benefits at the clinical trial stage. But with more and more studies being conducted on a global scale, the process of sourcing comparators is fraught with difficulty.
According to a poll conducted by Pharma IQ, ahead of next year's Clinical Trial Supply Europe event in Switzerland, complex supply chains are still the biggest challenge for drug developers trying to source comparators for clinical trials. Generally speaking, there are two main issues holding back the supply of comparator drugs – security and time delays.
|
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |